Free Trial

iRhythm Technologies (IRTC) Competitors

iRhythm Technologies logo
$136.77 -0.34 (-0.25%)
Closing price 07/29/2025 04:00 PM Eastern
Extended Trading
$136.77 0.00 (0.00%)
As of 04:12 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IRTC vs. SNN, SOLV, PEN, STVN, GKOS, BLCO, SLNO, INSP, TMDX, and NVST

Should you be buying iRhythm Technologies stock or one of its competitors? The main competitors of iRhythm Technologies include Smith & Nephew SNATS (SNN), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), Inspire Medical Systems (INSP), TransMedics Group (TMDX), and Envista (NVST). These companies are all part of the "medical equipment" industry.

iRhythm Technologies vs. Its Competitors

Smith & Nephew SNATS (NYSE:SNN) and iRhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, risk, dividends, valuation, institutional ownership, profitability, earnings and analyst recommendations.

25.6% of Smith & Nephew SNATS shares are owned by institutional investors. 1.0% of Smith & Nephew SNATS shares are owned by company insiders. Comparatively, 0.7% of iRhythm Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Smith & Nephew SNATS had 1 more articles in the media than iRhythm Technologies. MarketBeat recorded 6 mentions for Smith & Nephew SNATS and 5 mentions for iRhythm Technologies. Smith & Nephew SNATS's average media sentiment score of 0.99 beat iRhythm Technologies' score of 0.71 indicating that Smith & Nephew SNATS is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Smith & Nephew SNATS
5 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
iRhythm Technologies
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Smith & Nephew SNATS has a net margin of 0.00% compared to iRhythm Technologies' net margin of -15.90%. Smith & Nephew SNATS's return on equity of 0.00% beat iRhythm Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Smith & Nephew SNATSN/A N/A N/A
iRhythm Technologies -15.90%-101.04%-9.55%

Smith & Nephew SNATS has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Smith & Nephew SNATS, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Smith & Nephew SNATS$5.81B2.38$412M$2.1614.62
iRhythm Technologies$591.84M7.38-$113.29M-$3.14-43.56

Smith & Nephew SNATS has a beta of 0.69, suggesting that its stock price is 31% less volatile than the S&P 500. Comparatively, iRhythm Technologies has a beta of 1.41, suggesting that its stock price is 41% more volatile than the S&P 500.

Smith & Nephew SNATS presently has a consensus price target of $28.00, indicating a potential downside of 11.35%. iRhythm Technologies has a consensus price target of $137.30, indicating a potential upside of 0.39%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, analysts plainly believe iRhythm Technologies is more favorable than Smith & Nephew SNATS.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Smith & Nephew SNATS
0 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
iRhythm Technologies
0 Sell rating(s)
1 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.90

Summary

Smith & Nephew SNATS beats iRhythm Technologies on 11 of the 16 factors compared between the two stocks.

Get iRhythm Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IRTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IRTC vs. The Competition

MetriciRhythm TechnologiesMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$4.38B$2.16B$5.70B$9.55B
Dividend YieldN/AN/A4.71%4.03%
P/E Ratio-43.5637.3528.2019.95
Price / Sales7.3829.73390.5767.75
Price / CashN/A56.0636.3258.72
Price / Book47.169.128.275.77
Net Income-$113.29M-$63.64M$3.25B$259.21M
7 Day Performance1.59%-5.10%-2.00%-2.40%
1 Month Performance-11.17%7.82%8.68%9.41%
1 Year Performance53.50%5.35%34.66%16.67%

iRhythm Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IRTC
iRhythm Technologies
1.0189 of 5 stars
$136.77
-0.2%
$137.30
+0.4%
+54.4%$4.38B$591.84M-43.562,000Upcoming Earnings
SNN
Smith & Nephew SNATS
2.6175 of 5 stars
$30.26
+0.3%
$28.00
-7.5%
+9.8%$13.21B$5.81B0.0017,349Positive News
Upcoming Earnings
SOLV
Solventum
0.8843 of 5 stars
$72.37
-1.2%
$84.38
+16.6%
+28.3%$12.68B$8.25B13.4222,000Positive News
PEN
Penumbra
4.5769 of 5 stars
$228.19
-0.9%
$305.07
+33.7%
+27.5%$8.92B$1.19B215.284,500News Coverage
Positive News
Earnings Report
STVN
Stevanato Group
N/A€24.35
-2.2%
N/A+30.8%€7.37B€1.19B47.755,521
GKOS
Glaukos
4.3967 of 5 stars
$96.97
-0.7%
$134.67
+38.9%
-21.5%$5.58B$383.48M-40.92780Positive News
BLCO
Bausch + Lomb
2.0444 of 5 stars
$13.92
+0.1%
$15.45
+11.0%
-12.3%$4.92B$4.79B28.9613,500News Coverage
Earnings Report
SLNO
Soleno Therapeutics
4.3464 of 5 stars
$86.97
-0.3%
$108.70
+25.0%
+79.4%$4.39BN/A-18.8230Positive News
Upcoming Earnings
INSP
Inspire Medical Systems
4.8655 of 5 stars
$125.13
-1.3%
$210.27
+68.0%
-2.8%$3.74B$802.80M57.661,246Positive News
Upcoming Earnings
TMDX
TransMedics Group
1.9115 of 5 stars
$103.61
-5.7%
$129.88
+25.3%
-24.6%$3.72B$441.54M76.18210
NVST
Envista
2.6007 of 5 stars
$19.47
-0.2%
$20.23
+3.9%
+23.8%$3.31B$2.51B-2.9812,300Upcoming Earnings
Analyst Forecast

Related Companies and Tools


This page (NASDAQ:IRTC) was last updated on 7/30/2025 by MarketBeat.com Staff
From Our Partners